Date Posted: 02/20/2018
Expires On: 03/22/2018
Ad Number: 170115
Ad Information
Category:
Business Opportunities
Subcategories:
Other
Description
FDA (U S Food and Drug Administration) recently approved Transcatheter aortic valve implantation (TAVI) or replacement (TAVR) for the patients who have an intermediate risk with severe aortic stenosis. Know the complete information at Keystone Heart. For More Information: http://www.keystoneheart.com/us/clinical-evidence/clinical-studies/ info@keystoneheart.com 1 877 575 4433
